Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment
RA Schwartz, PH McDonough, BW Lee - Journal of the American Academy …, 2013 - Elsevier
Toxic epidermal necrolysis (TEN) is a life-threatening, typically drug-induced,
mucocutaneous disease. TEN has a high mortality rate, making early diagnosis and …
mucocutaneous disease. TEN has a high mortality rate, making early diagnosis and …
Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update
S Tas, T Simonart - Dermatology, 2003 - karger.com
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a rather distinct
severe adverse drug reaction characterised by skin rash, fever, lymph node enlargement …
severe adverse drug reaction characterised by skin rash, fever, lymph node enlargement …
Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review
R Gerull, M Nelle, T Schaible - Critical care medicine, 2011 - journals.lww.com
Objectives: The aims of this review are to summarize the definitions, causes, and clinical
course as well as the current understanding of the genetic background, mechanism of …
course as well as the current understanding of the genetic background, mechanism of …
Toxic epidermal necrolysis: review of pathogenesis and management
A Downey, C Jackson, N Harun, A Cooper - Journal of the American …, 2012 - Elsevier
Toxic epidermal necrolysis (TEN) is a severe cutaneous drug reaction with a mortality rate of
approximately 30%. The hallmark of TEN is widespread epidermal sloughing due to …
approximately 30%. The hallmark of TEN is widespread epidermal sloughing due to …
Pathogenesis of COVID‐19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx
HN du Preez, C Aldous, MR Hayden… - The FASEB …, 2022 - Wiley Online Library
The glycocalyx surrounds every eukaryotic cell and is a complex mesh of proteins and
carbohydrates. It consists of proteoglycans with glycosaminoglycan side chains, which are …
carbohydrates. It consists of proteoglycans with glycosaminoglycan side chains, which are …
Erythema multiforme and related disorders
Erythema multiforme (EM) and related disorders comprise a group of mucocutaneous
disorders characterized by variable degrees of mucosal and cutaneous blistering and …
disorders characterized by variable degrees of mucosal and cutaneous blistering and …
N-acetylcysteine in dermatology
M Adil, SS Amin, M Mohtashim - Indian Journal of Dermatology …, 2018 - ijdvl.com
N‑acetylcysteine is a mucolytic drug which is commonly used as an antidote for
acetaminophen toxicity. It is a thiol compound, which acts as a donor of cysteine, leading to …
acetaminophen toxicity. It is a thiol compound, which acts as a donor of cysteine, leading to …
Erythema multiforme, Stevens–Johnson syndrome and toxic epidermal necrolysis
SM Breathnach - Rook's textbook of dermatology, 2010 - Wiley Online Library
Clinically, erythema multiforme involves macular, papular or urticarial lesions, as well as the
classical iris or 'target lesions', distributed preferentially on the distal extremities. Lesions …
classical iris or 'target lesions', distributed preferentially on the distal extremities. Lesions …
Severe cutaneous adverse drug reactions: presentation, risk factors, and management
SS Mustafa, D Ostrov, D Yerly - Current allergy and asthma reports, 2018 - Springer
Abstract Purpose of Study Immune-mediated adverse drug reactions occur commonly in
clinical practice and include mild, self-limited cutaneous eruptions, IgE-mediated …
clinical practice and include mild, self-limited cutaneous eruptions, IgE-mediated …
Stevens–Johnson syndrome and toxic epidermal necrolysis: a review of treatment options
S Worswick, J Cotliar - Dermatologic therapy, 2011 - Wiley Online Library
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe
cutaneous reactions that are medication‐induced in most instances. While the clinical …
cutaneous reactions that are medication‐induced in most instances. While the clinical …